awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34134584-F2BC6C57-03BE-492A-B891-0D17A9A9CBFD
Q34134584-F2BC6C57-03BE-492A-B891-0D17A9A9CBFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134584-F2BC6C57-03BE-492A-B891-0D17A9A9CBFD
Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.
P2860
Q34134584-F2BC6C57-03BE-492A-B891-0D17A9A9CBFD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34134584-F2BC6C57-03BE-492A-B891-0D17A9A9CBFD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0aff14995df52f56cdcf3e549422bd7b478d866c
P2860
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (